Valneva SE
| Use attributes for filter ! | |
| Stock price | VLA |
|---|---|
| Disclaimer | |
| Headquarters | France |
| Founded | 2013 |
| CFO | David Lawrence |
| Subsidiaries | Valneva USA, Inc. |
| Valneva UK Limited | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1165302 |
About Valneva SE
Valneva SE is a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs. Valneva was founded in 2013 through the merger of Intercell and Vivalis SA. It has been listed on the Vienna Stock Exchange and Euronext since May 28, 2013.
